Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Page 2

Corporates help set down $15m for Hunters
Cyber threat detection startup Hunters has pulled in series A funding through a round co-led by M12 that also featured Okta Ventures.
Owkin expands series A to $70m
BPIfrance’s Large Venture fund and Mubadala Capital added $18m to the medical data research platform's GV-backed series A round.
Hopin ropes in corporates to raise $40m
Salesforce Ventures and returning investor Slack Fund helped the virtual event provider add series A funding to the seed round it closed four months ago.
Simcha shakes down $25m
Wuxi AppTec and Pfizer contributed to a series A round that will support progress of Simcha Therapeutics' immuno-oncology treatments toward clinical trials.
Artiva arrives with $78m
Artiva Biotherapeutics is leveraging GC LabCell’s cell therapy technology to target cancer, and has raised series A funding from backers including the latter.
Corporate venturing deal net: 22-26 June 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
GV helps Sana secure $700m
Sana Biotechnology has closed its first round at more than $700m after investors including GV swung behind its vision to commercialise cell therapies.
Landed gets handed more series A cash
The Lowe's-backed home finance provider increased its overall equity funding to more than $22m in a second series A tranche led by Omers Ventures.
Openly ropes in Google for $15m series A
Google's Gradient Ventures unit led a seed round for the online homeowners insurance platform late last year and has returned for its series A.
Nan Fund enters Engrail in $32m round
Engrail Therapeutics has completed a series A round led by Nan Fung Life Sciences as it targets a validated mechanism-based approach to nervous system treatments.

test reg